In this study, an increase in PRDX6 was observed in SLE and LN, suggesting a predominant inflammatory response through the elevated oxidative stress-mediated signaling pathway, which is consistent with findings in some autoimmune diseases (21, 29, 30). Here, PRDX6 is linked to autoimmune disease.